Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Director's Dealing 2023

Sep 18, 2023

3782_dirs_2023-09-18_7aa0291c-0fb3-489b-b36a-b691911b622a.html

Director's Dealing

Open in viewer

Opens in your device viewer

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade

Saga Pure ASA has on 18 September 2023 purchased 100,000 shares in Vistin Pharma

ASA at NOK 23,50 per share.

After the transaction Saga Pure ASA has a holding of 100,000 shares,

corresponding to 0.23 % ownership. Saga Pure ASA is closely associated with

board member Øystein Stray Spetalen.